BOLD Stock Analysis: Buy, Sell, or Hold?
BOLD - Boundless Bio, Inc. Common Stock
$1.09
-0.03 (-2.25%)
▼
5d:
-5.65%
30d:
-6.47%
90d:
-9.58%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 08, 2026
Get Alerted When BOLD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BOLD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BOLD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BOLD is currently trading at $1.08, which is considered oversold relative to its 30-day fair value range of $1.12 to $1.17.
Technical Outlook: Technically, BOLD is in a downtrend. The price is currently testing key support at $1.07. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BOLD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.00 (+260.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BOLD is in a downtrend. The price is currently testing key support at $1.07. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BOLD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.00 (+260.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.12 -
$1.17
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 260.4% below Wall St target ($4.00)
- CAUTION: 5-day price weakness (-5.7%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.12 -
$1.17
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.07
Resistance Level
$1.22
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.86
Wall Street Target
$4.00
(+260.4%)
Share & Embed Analysis
Last updated: March 30, 2026 4:48 PM ET
Data refreshes hourly during market hours. Next update: 5:48 PM
Data refreshes hourly during market hours. Next update: 5:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BOLD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 61 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 58 HOLD |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
15 analysts |
$669 | 67 BUY |
